Education and Work Experience 1991.09–1996.06: Bachelor of Clinical Medicine, Sun Yat-sen University of Medical Sciences 1996.07–2001.12: Resident Physician, Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-sen University 1999.09–2004.06: Combined Master and Doctoral Program, Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-sen University 2002.01–2007.12: Attending Physician, Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-sen University 2002.06–2002.11: Visiting Research Fellow, Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Germany 2008.01–2012.12: Associate Chief Physician, Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-sen University 2008.08–2009.07: Visiting Research Fellow, Laryngology Unit, Queen Mary Hospital, The University of Hong Kong Medical Centre 2011.04–2011.10: Visiting Research Fellow, Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, USA 2013.01–Present: Chief Physician, Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-sen University 2014.02–2015.02: Executive Vice President, Hainan Provincial Otorhinolaryngology Head and Neck Surgery Hospital 2015.12–Present: Director of Laryngology Section, Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-sen University 2019.09–2019.09: Visiting Scholar, Head and Neck Surgery, MD Anderson Cancer Center, Houston, USA 2022.04–Present: Department Director and Teaching Section Director, Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-sen University

Clinical Expertise With nearly 30 years of practice in otorhinolaryngology, he specializes in surgical resection and functional reconstruction of laryngopharyngeal and head-neck malignant tumors, as well as single or combined repair using various regional flaps. He treats more than 300 patients with laryngopharyngeal cancer annually and performs nearly 200 complex operations for laryngeal cancer, hypopharyngeal cancer, upper esophageal carcinoma and other laryngopharyngeal and head-neck malignancies each year, with 60% of the procedures classified as Grade IV surgeries. He also has extensive clinical experience in immunotherapy for laryngopharyngeal and head-neck malignant tumors. He is skilled in microscopic CO₂ laser minimally invasive techniques for early laryngopharyngeal malignancies, recurrent laryngeal cancer, recurrent respiratory papillomatosis and voice surgery. He is experienced in the diagnosis and management of sleep-disordered breathing in adults and children.